Table 1.

Included studies

Authors and year	PET tracer	Subjects	Glioma type	Patients received therapy before
Bšelohlávek et al., 2002	18F-FDG	29	LGG, HGG	+
Pauleit et al., 2005	18F-FET	28	WHO grade I~IV	–
Walter et al., 2005	18F-FET	45	WHO grade I~IV	+
Pirotte et al., 2006	11C-MET, 18F-FDG	103	LGG, HGG	–
Mira et al., 2004	11C-MET	10	GBM	–
Yamamoto et al., 2006	18F-FLT	10	GBM (recurrent)	+
Galldiks et al., 2010	11C-MET	12	Glioblastoma	+
Ewelt et al., 2011	18F-FET	30	WHO grade II~IV	–
Santra et al., 2012	18F-FDG	90	WHO grade I~IV	+
Arbizu et al., 2012	11C-MET	23	WHO grade II~IV	+/−
Jansen et al., 2012	18F-FET	127	WHO grade I~IV	–
Singhal et al., 2012	11C-MET, 18F-FDG	102	WHO grade I~IV	NA
Nowosielski et al., 2014	18F-FET, 18F-FLT	23	WHO grade III, IV	–
Zhao et al., 2015	18F-FLT	19	WHO grade III, IV	+
Song et al., 2016	18F-FDG	70	NA	–

NA = not available